Please login to the form below

Not currently logged in
Email:
Password:

Hong Kong

This page shows the latest Hong Kong news and features for those working in and with pharma, biotech and healthcare.

Inovio plans late-stage COVID-19 vaccine study in second quarter 2021

Inovio plans late-stage COVID-19 vaccine study in second quarter 2021

As part of this agreement, Advaccine will gain exclusive rights to develop, manufacture and commercialise INO-4800 within Greater China, including Mainland China, Hong Kong, Macao and Taiwan.

Latest news

More from news
Approximately 2 fully matching, plus 74 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax, The University of Hong Kong, The University of Oxford, The University of Queensland and a

  • Is China ready for a pharmaceutical gold rush?

    Public trading barometer. Another potential barometer of China’s free market access will be how the sector fares on the Hong Kong Stock exchange. ... Hong Kong is an attractive spot for Chinese biotech listings as firms from here and the wider region

  • Deal Watch October 2018

    Gilead’s subsidiary, Kite, has agreed a deal for a research collaboration with HiFiBiO Therapeutics, the Hong Kong-based company which is working on the discovery of therapeutic antibodies through single

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene aims to be the first home-grown big biopharma. BeiGene is one of a new wave of Chinese biopharma companies to list on the Hong Kong stock exchange, raising a ... However while there are doubts about the robustness of some of the ‘pre-revenue’

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    scale.”. Having just raised a gargantuan $903m via an IPO on the newly deregulated Hong Kong exchange, the company is bullish about becoming one of those Chinese-headquartered global pharma companies, ... In terms of biotech funding, the emergence of

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics